IAVI Reports Safety Signal with HIV Vaccine in Clinical Trials

The International AIDS Vaccine Initiative (IAVI), is a global not-for-profit public-private partnership working to accelerate the development of vaccines to prevent HIV infection and AIDS. IAVI researches and develops vaccine candidates, conducts policy analyses, serves as an advocate for the HIV prevention field and engages communities in the trial process and AIDS vaccine education. It also works to ensure that future vaccines will be accessible to all who need them. The organization recently announced they are in the process of finalizing and submitting a manuscript for publication of the results of the IAVI G002 clinical trial. The forthcoming publication will describe in detail both the immune responses and the safety outcomes observed in the trial. Among the findings are the observations concerning skin events.

Observations